Show UniProt / TrEMBL protein name		View in Fasta format (DNA)		View as list

# Vibrio vulnificus YJ016, YJ016

>gid:513501  VV0037  putative multidrug resistance protein
MRFTDVFIKRPVLAVSISFLIALLGLQAVFKMQVREYPEMTNTVVTVTTS
YYGASADLIQGFITQPLEQAVAQADNIDYMTSQSVLGKSTITVNMKLNTD
PNAALADILAKTNSVRSQLPKEAEDPTVTMSTGSTTAVLYIGFTSDELSS
SQITDYLERVINPQLFTINGVSKVDLYGGLKYALRVWLDPAKMGALRLTA
TDVMGVLNANNYQSATGQVTGEFVLYNGSADTQVSNVQELENLVVKSGDG
EVIRLGDIAKVTLEKSHDVYRASANGQEAVVAAINAAPSANPINIAADVL
KLLPQLERNLPSNIKMNVMYDSTIAINESIHEVVKTIVEAAVIVLVVITL
FLGSFRAVIIPIVTIPLSLIGVAMVMQAMGFSWNLMTLLAMVLAIGLVVD
DAIVVLENVDRHIKEGESPFRAAIIGTREIAVPVIAMTLTLGAVYAPIAL
MGGITGSLFKEFALTLAGSVFVSGIIALTLSPMMCSKMLKAHEKPSKFEE
KVHHVLDGMTNRYEKMLKAVMDHRPVVIGFALIVFGTLPVLFKFIPSELA
PSEDKGVVMLMGTGPSNANLDYLQNTMNDVNKILSDQPEVEFAQVFTGVP
NSNQAFGLATLKPWSQREASQAEITKRVGGLVSNVPGMAVTAFQMPELPG
AGSGLPIQFVITTPNSFESLYTIASDILTEVTSSPLFVYSDLDLKYDSAT
MKIKIDKDKAGAYGVTMQDIGITLGTMMADGYVNRIDLNGRSYEVIPQVE
RKWRLNPESMKNYYVRAADGKAVPLGSLITIDVIAEPRSLPHFNQLNSAT
VGAVPSPGTAMGDAINWFENIASSKLPTGYNHDYMGEARQFVTEGSALYA
TFGLALAIIFLVLAIQFESIRDPIVIMVSVPLAICGALIALAWGLATMNI
YSQVGLITLVGLITKHGILICEVAKEEQLHNKRSRIDAVMEAAKVRLRPI
LMTTAAMIAGLIPLMYATGAGAAQRFSIGIVIVAGLAIGTLFTLFVLPVI
YSYLAEKHKPLPVFVEDKDLEKLARVDEAKAAQRQIAEQ
>gid:513606  VV0137  multidrug resistance efflux pump
MSDNNVQTSAEQSDKKISQARSFTYYIFALVAALWLYTLWADRMTPMTDQ
ARVNGQLIRISPEVSGPISQVLITNNSIVKAGDELVTIDPRPFELAVKAA
KFDLQQAAQSYEADSAAISVAQANEVAARVKVNNAKKNVERNRVLANKGT
ISQAVMDNIIAELETAQAGLAQASSALEKAKQEFGPRGIDNPEIQSVLNR
QEQALLNLNHTKLTAPANGVITNMDVAVGDYAAAGQPLLTFINNNNLWLT
AMVRENSLAHLKPGDKVKIVFDANPGEVYEGKISSIGWGSSGNGSLAQDA
SNGLMTSPTSSSKAQRFPVNIEFMELPADLNLRYGGRAVVGFYPDESYLG
ERLQDLWIWAWSYISYVS
>gid:513742  VV0265  type I site-specific restriction-modification system, R (restriction) subunit
MRWISGLDLVAHQMTARKKNSMALNEADTCRVYVTPKLKESGWENNPSAI
TEQYTFTDGRVQFKGSKVQRGEQKRADYLLKYTRDFPIAVVEAKPENSPV
GQGMQQAKDYAEILGLKFAYSTNGHEILEFDYTTGEEQLLSRFPTPDELF
KRLCGDEGIKDEDLDTLLSPYHHVSGYSPRYYQQIAINRAVQSVLQGKKR
SLITMATGTGKTVVAFQISWKLWSARWNRTGDYRKPRILFLADRNVLVDD
PKDKTFTPFGDARHKIEGGKVVKSREIYFAIYQSIASDERRPGLYKEFPQ
DFFDLIIIDECHRGSARDNSNWREILEYFEPAFQIGMTATPLREDNRDTY
RYFGNPIYTYSLRQGIDDGFLAPYRVHRVISEVDAAGWRPSKGDVDRFGR
EIPDGEYQTKDFERVIALKARTDAFAKHLTDFMKRTDRFAKTIVFCVDQE
HADEMRRALNNLNSDLSRKHPDYVARVTSEEGKIGKGHLSRFQELETSTP
VILTTSQLLTTGVDAPTCKNVVLARVVNSMSEFKQIVGRGTRLREDYGKL
WFNIIDYTGSATQNFADPDFDGYPEIEDEVVIDEDGEEVVDDTLTPESEV
LEVAEETGEYEVNTEGEGADDEEEHEPRKYYVDGGSVKITSHLVYELDED
GKQLRVIQYTDYTAEKVKTLFSSLDELKDSWANPLKREEIILELQERGIQ
FEDLVAESGKTDADPLDLLCHIAFNVPLRTRKERADYLKKNKPDFFDQYG
PEARAILTSLLDKYTDHGPKQFSIPDSLQVPPISEYGNVMEIANLFGGAL
QMKTAVDQLQTLLYSQQ
>gid:513743  VV0266  type I restriction-modification system methyltransferase subunit
MTIRFMARTKKADQPMTTAQQLGAIVKSSRQIMRKDKGLNGDLDRLPMLT
WIMFLKFLDDLEQMRETEAVLEGKSFQPAIEAPYRWRDWAAIEGGITGDE
LIAFINNDEAMRPDGTRGIGLFAYLRSLQGDNGGDRRDVIATVFKGMQNR
MINGYLLRDVVDKINGIHFNSSEEMHTLSRLYETMLREMRDAAGDSGEFY
TPRPVVRFMVEVMDPQLGESVLDPACGTGGFLVEAFEHLERQCKTVEDRE
VLQESSIFGGEAKSLPYLLVQMNLLLHGLEYPRIDPENSLRFPLREMGDK
DRVDVILTNPPFGGEEEKGILGNFPEDMQTAETAMLFLQLIMRKLKRPGH
GSDNGGRAAVVVPNGTLFSDGISARIKEELLKNFNLHTIVRLPEGVFAPY
TDIAGNLLFFDRSGPTDDIWYYQITVPEGRKKYTKTKPMESHEFDECLNW
WSNRIVNQNAWKESASEIIKYSESGQLIDVNLDRKNPNSLEVLEHEEPMD
LIEKITTKEESLLAILEQIKAEISTQGISK
>gid:513744  VV0267  type I restriction-modification enzyme, specificity subunit
MKEYTLRDVLIRQKEAITVEDDAEYKRITIKMNGNGVLLRDEVIGDAIGT
KRQFLVSSDQFVLSKIDARNGAFGIVPKSCDGAIITGNFWAFDVNSELAD
VKYLDFMSKTPEFKDFCIVASEGTTNRKYLDENKFLDKRILLPELAEQKK
VVAKILKFKNKIELARKIRNEILSDLYVLLNSTFHKLIEGAVYKPMSKVA
PLERRKVEIDVNAEYPELGVRCFGNGTFHKPILNGMDVGTKKLYQMVPGD
LVFSNVFAWEGAIAVVKKEDEGRVGSHRFITCLPKSGVVTADFLCFYFLT
TEGLEKIQAASPGGAGRNRTLGLKKLENIEVPVPDYDKQLWFNQLQSYVE
KIKQAQSENATELEALMPSILDKAFKGELV
>gid:513906  VV0418  ABC-type antimicrobial peptide transport system, permease component
MSATMTLAWKSLRNRKATAFLTVLTVAISVILLLGVEKIRTQAKESFANT
ISGTDLIVGGRSGQVNLLLYSVFRIGNATNNIDWKSYQDFANHRAVAWAI
PISLGDSHKGFRVMGTNHSYFEHFKYGSKQPLTFSQGKPFNGLFETVLGA
EVAKQLGYQIGSEIIIAHGISDVGFSRHDNLPFKVVGILAPTGTPVDKTV
HVSLEAIEAIHVGWESGARLGPSPDATQLEQKQFQPKQITAMMLGLKSRI
QTFALQREINTYNQEPLSAIMPGVALHELWGMMSVAEQALMAVSVFVVIA
GLLGMLSSLLTSLQERRREMAILRAMGARPRHVFTLLISEASLLTLAGIV
TGVAGVYGLLSIAQPIIQQQYGINITMTAISPHEWMLLAFVQTAGILIGF
IPAIRAYKQSLSDGMTIRI
>gid:513907  VV0419  ABC-type antimicrobial peptide transport system, ATPase component
MVNTSPAVIELQQVSFTWKEATQPILQIPHFSVARGEHVFIKGPSGCGKS
TLLSLLTGINQVQSGQLTILGTELAALSPSQRDKFRADNIGYIFQQFNLL
PYLNVLENVLLPCQFSRTRATHVEGDARAKAAQLLTRLHLPQSLHLKSVS
ELSIGQQQRVAAARALIGAPALVIADEPTSALDFDNRSAFIELLMEQANA
ANATLVFVSHDPTLERLFDRTVDLRQLNQAGEAS
>gid:514021  VV0531  transposase
MHEDKELFDKLNLSVYEIVFYRALVENEASVHELGYHALRNLAIELTVQL
RNSATLDWQKRDSVRARMRNLVCRLLRRRPYPLETMFRIHCMQQWYSLGD
EATEDALYEIASMRQFARLSLDKAIPDRTSIMNFRHMLEKHKLTRKSFKT
VNQWLSDCGVMMTQGTLVDATIIEAPSSTKNKNNERDPDMHQTRKGNEWY
FGMKAHIGVDANSGLTHTLVTTAANEHDLNQLNKLLHGEEEFVSGDAGYQ
GAEKREELEDADVEWLIAERPSKVRALKKHPRKNKTAIRIEYLKASIRAK
VEHPFRIIKCQFGFIKTRYKGLMKNDSQLAMLFALANLFKVDQMLRRQPR
SV
>gid:514062  VV0570  putative undecaprenol kinase
MSYFEAFVLALIQGLTEFLPISSSAHLILPSAILGWEDQGLAFDVAVHVG
TLAAVVIYFRKEVITLFAALFASIFKGERSKEAKLAWMIVIATIPACIFG
LVMKDVIEVYLRSAYVIATTTIIFGLLLWWVDKNASLLDDEYQAGWKKAL
FIGIAQALAMIPGTSRSGATITAALYLGFTREAAARFSFLMSIPIITLAG
SYLGLKLVTSGEPVHVGFLLTGIVTSFISAYLCIHLFLKMISRMGMTPFV
IYRLILGVGLFAYLLMA
>gid:514314  VV0813  type I site-specific restriction-modification system, R (restriction) subunit
MITKEAQIEQALIDKLGDLKYSYRKDIRTDRALKQNFREKFEALNFVNLT
DNEFERLYQDIITADVFEAAKTLRERGYFQREDGTPLHYTLVNIKDWCKN
EFEVINQLRMNTDESNHRYDVILLINGVPTVQIELKAYDIVTRRAMEQIV
DYKNDIGNGYTNTLMCFIQMFIVSNEHHTYYFANNRSEHFSFNADERFLP
VYQLANENNRKISHLHDFADAFLAKCTLGQMISRYMVLVQSEQKLLVMRP
YQIYAVEAIVDCIHEGRGNGYIWHTTGSGKTLTSFKASTLLKDNPDIEKC
LFVVDRKDLDRQTREEFNKFQDGCVEENTNTETLVRRMLSEDYADKVIVT
TIQKLGLALDENSKRNQSKLREGKKTFKERLEPLRDKRIVFIFDECHRSQ
FGENHKAIKEFFPEAQLFGFTGTPIFEKNSTYTQIDGNVGSFKTTESIFE
QELHHYTITHAIEDKNVLSFHIDFFGKHSASKQLADASNDEAEATVTRVT
PPPRAVVQEILEKHDAVTNHRRFNAILATASINHAIEYFEEFKSQQELKA
SESEDYIPLNIACVFSPPAQLSDKDKEDSDLNTLARNVKDIQQLQEDLPQ
EKADNEVEPERKKQALVDIINSYNHQYSTNHTINEFDLYYQDVQQRIKDQ
QYDNADYPHKNKIDIVIVVDMLLTGFDSKYLNTLYVDKNLKHHGLIQAFS
RTNRVLNDSKPWGNILDFRGQEKEVNEAIKLFSGKKEEGAEQIWLVDPAP
VVVDKYKEAVDKLEAFMQKQGLACEPSEVTNLQGDAQRASFINHFKEVQK
FKNQLEQYTELDDEQKAQVAATLPIDTLRGFKGAYLETAKDLKRKLDTNK
GAGDLPEEVEQLEFEFVLFASALIDYDYIMGLIAKSTQGTSKQSMTRQQL
IDLICSQANLMSERDELIAYIHSLPSGEALNVSQIHAGYQAFKMKKATSE
LNDMAIKHGLTTESLQAFVDGIMGRMIFDGEKLGDLLEPLELGWKERTKK
ELALMEDLVPYLHKLAQGREISGLAAYE
>gid:514315  VV0814  restriction endonuclease S subunit
MSKLEFKELVPELRFSQTEWQKKPFNKLYTLKVTNSLSRDKLNYDDGLVK
NIHYGDIHTKFSTLFDITKEYVPFINTEISLDKVKEESYCQEGDMVFADA
SEDIDDVGKSIELINLNGEKLLSGLHTILARPKKSDLVKGFGGYLFKSEV
MRKQIQKESQGAKVLGISASRISNIEVIYPIDHDEQQKIADCLSSMDDLI
TTNTKKLELLKLHKKGLLQKLFTAEGKDIPELRFDGFEGEWEEVELRKLG
DLISGLTYSPDDVRASGLLVLRSSNVQNGKIVYGDNVFVEPNIKGANISE
PDDILICVRNGSKALIGKNALIPQNVPLSTHGAFMTIFRSKYAQFTFQLF
QTNAYQKQVDADLGATINSINGKQLLKYKFKIPRSNDEKEKIVKCLSSLD
DLINAQTDKIEVLKEYKKGLMQQLFPKIKESIA
>gid:514317  VV0816  type I restriction-modification system methyltransferase subunit
MTQEQLNKLGKTLWDIADTLRGAMNADDFRDYMLSFLFLRYLSDNFEAAA
KKELGKDYLDLPKDVLRDLKMSNPLEVWYDENPDDISFFETQMRRKLHYI
IKPEHLWSSIAEMARVQDDELLKTLEEGFKYIENESFNSSFQGLFSEINL
NSEKLGKKPSDRNAKLCTIIQKVSEGIAQFSTDTDILGDAYEYLIGEFAA
NGGKKAGEFYTPQPISTILSEIVTLDSQEPKMGKKNKLNRVLDFACGSGS
LLLNVRKHITVAGGSIGKIYGQEKNITTYNLARMNMLLHGVKDTEFDIFH
GDTLFNDWELLNEKNPAKKLKFDAVVANPPFSYRWESDRAEFKEDFRFKN
HGIAPKSAADFAFLLHGFHFLSDEGTMAIILPHGVLFRSGAEQRIRSKLL
KDGHIDTVIGLPSNLFFSTGIPVCILVLKKCKKYDDVLFINASDEENFEK
GKRQNKLRPEDIQKIVDTYRFRDQEERYSRRVSMEEIEKNDFNLNISRYV
STAKAEAKVDLQAEHKKLVDIEKNINEALDKHNSFLKELGLPPLPR
>gid:514353  VV0851  conserved hypothetical protein
MKKTITKVVALSVAAMALSGCVGSNAVTGYVMGFNLKAVDNRYARGGLNM
LLAPVYGVAIAADYIVFNSLEFWTGKNPLNGKPHIFDTKMDTYIDVNHQL
DKSLTTAPIAPLTNNRIIEQGMMQQIDENTVQMDITYNNGEKATLTGVRE
GDFVTYYIDGEVVAQTSMDELAAYAQNRA
>gid:514653  VV1129  putative multidrug resistance protein
MLLSDVSVKRPVAALVLSLLLCVFGFVSFSKLAVREMPDIESPVVSISTR
YDGASATIIESQITSVLEDQLSGISGIDEISSTTRNSMSRITITFELGYD
LNTGVSDVRDAVARAQRSLPEEADDPIVFKNNGSGEASVYINLSSSEMDR
TQLTDYIERVLMDRFSLITGVSSVDISGGLYKVMYVKLSPELMAGRGVTA
TDITAALRSENLESPGGQVRNDQTVMSVRTARSYNSVEDFQYLVVKRASD
NTPIYLKDVADVFIGAENENSTFKSDGVVNVSMGIVPQSDANPLEVAKRV
HEEVDKVQKFLPEGTRLAIDYDSTVFIERSISEVYSTLFITGGLVILVLY
IFIGQARATLIPAVTVPVSLISSFIAAYYFGFSINLITLMALILSIGLVV
DDAIVVVENIFHHIEKGESPLLAAYKGTREVGFAVIATTLVLVMVFLPIS
FMDGMVGLLFTEFSVLLAMSVIFSSLIALTLTPVLGSKILKANVKKNRFN
DVVDVLFGKLESGYRALLKRALAWRWLAPVIILACMGGSYALMNQVPAQL
TPQEDRGVIFAFVRGADATSYNRMSANMDLVEERLMPLLGQGFLKSFSIQ
SPAFGGQAGDQTGFVIMILDDWNERSVTAQQALGEVRKALAGIPDVRVFP
FMPGFRGGSSEPVQFVLGGSDYNELRDWAEVLKNKAEESPIMEGAEINYS
EKTPELVVSVDKRRAAELGISIKEISDTLEIMLGGRKETTFVERGEEYDV
YLRGDENRFNNAADLSQIYLRTKSGDLVTLDTVTNVEEIASSIRLSHYNK
QKAITITANLSDGYTLGDALDFLDQQAIETLPGDITISYSGESKDFKENQ
SSVAIVFALALLVAYLVLAAQFESFINPLVVMFTVPMGVFGGFLGLLIMQ
QGMNIYSQIGMIMLIGMVTKNGILIVEFANQLRDRGFEFEQAIIDASARR
LRPILMTAFTTLAGAIPLILSDGAGYESRVAVGTVIFFGMGFATLVTLFV
IPAMYRLISRYTEAPGHVEAELNQALSHDTKGRVSHG
>gid:514923  VV1386  ABC-type antimicrobial peptide transport system, ATPase component
MSALLEVENLSKNFVTRSGLFKREVQQAVKPVSFTLEAGQTIGFIGQNGS
GKSTLARMLAGMVEPTSGEIRVNGERLEHRDYATRCKLIRMIFQDPNTSL
NPRIQIGRILEGPLKRNTNMPPEARLKRVKDTLLRVGLLPEHAYFYPQML
ATGQKQRVCLARALILQPSIIVADEALNGLDMAMRSQIINLFLELQEEMG
VSFVYVSQHIGIVKHITDKVMVMHEGEVVESGDTQIVLSDPQHPLTQRLV
ENHFYKTPSHY
>gid:514924  VV1387  ABC-type antimicrobial peptide transport system, ATPase component
MELHFAERTDRDCDRNYLGAVCCCFRHHRAWLSGAGGTSTEHRMGRNSWR
FRGADLSRALDRNTARIVHYVYRYRHQPCRGWRTPSSQCGDRIMPLLDIR
HLTIEIETPQGLVKAVDRMSLTLNEGEIRGLVGESGSGKSLVAKAIVGVC
KDNWRVTADRMRLGNIDLLQLTPSERRRVIARDIAMIFQEPSTCLDPSEE
VGKQLIESIPSRTFEGKWWERFKWRKKRAIALLHKVGIKDHQRLMKSYPY
ELTDGECQKVMIAMAIATAPKLLIADEPTNDLDPITQNQILRLLSRMNQL
NNTTILLIGHDLTNITQWANRITVMYCGQSVESADTDRILEAPKHPYTAA
LLKAMPDFSHWIPHKQKLQSLPGSIPPLQHLPIGCRLGPRCPYAQRQCVE
IPYARRIKNHKFSCHFPLNTEKDS
>gid:514925  VV1388  ABC-type antimicrobial peptide transport system, permease component
MLTDSVYQEEHIPTQFERFWRSFRNNNLAMFGLWCLILLLLVTISAPWLV
PHDPQQQTAQLLVPPSWSPAGTVEYFLGTDDLGRDILSRLIMGTQPTFGA
AIIITAIAAIIGCFIGVLAGMTRGLLSSTLNHLLDTVMSIPSLLLAIIFV
AFFGVGEFTVLLAVGLALIPRFIRSVYIAIHTEVEKDYIMAARLDGANSF
YLLWNSILPNVLTVIATEITLALSVAVLDITALGFLGLGAQAPSTEWGAI
LGDSVELIYLAPWTVTLPGLSIMFTVIVINLVGDGVRRALNAGIE
>gid:514926  VV1389  ABC-type antimicrobial peptide transport system, permease component
MMFWYAVRRLNLFVITLAILTMVGFSILRLDPESVWAQAEYWHGWSIYLS
ELAQLNFGVSKSGAAIYDELAVVFPATLELCFFAFLVALLIGIPFGTIAG
MKQGKWVDTTISFVSMSGYSAPLFWVALLMLMVFSLHFEIFPVSGRYDLL
YEIKHVTGFAIIDAFLAKGPYKAHALQSVIEHMVLPCLVLALAPTTQVIG
LMRASVADVMSQNYIRAARIKGLTTREIVTQHVLRNAIPPIIPKVGVQLS
SMLTLAIITESIFNWPGIGRWLLDALSNRDYVSIQAGVMVVATLVLTANI
LSDLIGAMINPLVRKEWYANR
>gid:514934  VV1397  transporter, AcrB/D/F family
MSDKPVVSPQSDDEVTGVAAYFIRNRVISWMISLIFLIGGVAAFFGLGRL
EDPAFTIKDAMVVTSYPGATPQQVEEEVTYPLEKAIQQLTYVDEVNSISS
RGLSQITVTMKNNYGPDDLPQIWDELRRKVNDLKGQLPPGVNDPQVIDDF
GDVYGILLAVTGDGYSYKELLDYVDYLRRELELVDGVSKVSVTGQQQEQV
FIEISMKRLSSLGISPNTVFNLLSTQNVVSDAGAIRIGDEYIRIHPTGEF
QNVDQLGDLIITESGAQGLIYLRDVADIKRGYVEVPNNIINFNGKLALNV
GVSFAQGVNVVEVGKSFDRRLAELKYQQPVGIDISEIYSQPKEVDKSVSG
FVVSLGQAVAIVIIVLLFFMGLRSGLLIGLILLLTVLGTFIFMQYFKIDL
QRISLGALVIALGMLVDNAIVVVEGILIGTQKGRTRLQAATDIVTQTKWP
LLGATVIAVTAFAPIGLSEDATGEYCGTLFTVLLISLMLSWFTAISLTPF
FADIFFKGQKVNVSESGEEVDPYNGMIFVVYKNFLEFCMKRAWLTMIVLV
LGLGVSLYGFTLVKQAFFPSSTTPMFQADIWLPEGTDIRATNTKLKALES
WLAEQDNVEHITTTAGKGLQRFMLTYAPEKSYAAYGEITTRVTSYEALDP
LMAKFRQHVKENFPEINYKLKQIELGPGGGAKIEARIIGSDPTVLRSIAA
QVMDIMYADAGATNVRHDWRERTKVLEPQFNESQARRYGITKSDVDDFLA
MSFSGMAIGIYRDGTTLMPIVARLPDEERVDIRNIEGMKIWSPALSEFIP
LQQVTLGYELLWEDPIIVRKNRKRVLTVMADPDILGEETASTLQKRLMPQ
IEAIQLPPGYSLEWGGEYESSRDAQASLFTTMPMGYLFMFLITVFLFNSV
KEPLIVWLTVPLAVIGVTTGLLALNTPFGFMALLGFLSLSGMLLKNGIVL
LDQIEIEMKSGKDPYVAVVDAALSRVRPVCMAAITTILGMVPLLPDIFFK
PMAVTIMFGLGFATILTLIVVPVLYRLFHKVAVPK
>gid:514968  VV1431  ABC-type antimicrobial peptide transport system, ATPase component
MIRSMLQLSDLCKGYVDGGEFHPVLQGAELSLKQGEQLALMGESGSGKST
LLNLISGLDIVDSGEIMFPGFAMNDAPEHLRTAYRRNNIGHIFQQFNLLP
TLNIADNIRFCRQLKGLPDDKGLWRQILSALDLMPLLGRYPEEVSGGQQQ
RAAIARALYMEPKLLLADEPTGSLDERNAEAVMRLLTSLTRQLDCTLLLV
THSEKVAKHMEGMIRLQGGQLHVMARS
>gid:514969  VV1432  ABC-type antimicrobial peptide transport system, permease component
MLWPVVKALLGHYRRYPLQILLVWLGLTLGVSLLVGVTAINHHAQESYQN
GEKLFNNPLPYRIRPKHSANKIPQGFYIQLRRAGFQQCTPFDMHHIKTAD
GMGLMLIGMDPVAMLQLEKETSLNRATSLALMNPPYPILISQDLAEHMAW
QDGDFIALEDGSQLGPLRVDREQRLNGSRMVADISLLRMLKRSSGLSVIA
CAEMPPEKLEHLKRYLPNGLTLVRNSQDELESLTKAFHLNLTAMGMLSFL
VGLFIFYQAMSLSLIQRQPLVGIMRQTGVTGMQLAKALLLELTILVLVAW
ACGNVLGLFLANELIPAVSASLGDLYDANVGLSIGWSWESSLYSLLLAVL
GALISCLWPLIRLLKSQPIRLSAKLSLVRFAGKEFAWQALAACGFAVAAI
AVYQAPKTPESGFTIIALMLMSVALFMPFLMWKVFNSFSYTLRWVNLRWF
FADMAASMSYRGVAMMAFMLALAANIGVETMVGSFRDTTDKWLTQRLAAD
LYIYPTNNSAARLSNWLEAQPEVDEVWWRWEKELADERDIVQVVSTGPSD
GELEALTVKLGVPNYWYHLHHSKSVMISESMALKLDIRPGDYLDLAAPLG
GGWLVVGVYYDYGNPYNQVLLSHRNWLYAFAGSGNVGLGVLLKDNVNGEG
LKHRLENIFRLTSERVFDNNNIYSQAMRVFDHTFAIADTLGNITLVIAVF
GLFFATLAGEMSRQKNISILRCLGVSGKELIILGGLQLFVFGVISALIAV
PLGMALATLVVDIVIKQSFGWSLQLQIDVIEYGETILWAMIAIMLAGALP
VIRLVKNTPMKSLRDSF
>gid:515140  VV1599  ABC-type multidrug transport system, permease component
MSLFELFKAEIKALFTNPVVTLTVFGGVVFYSFLYPLPYANQTPREQTIS
VVNLDMSATSLKLERMVDATPQVHVVRRDYTIESAKQAFLEGKISGILVI
PEHFYRDLLLGKSPTLSYAGDASYFLVYGTVVEGLAQTGGTLAAQVKVSK
LVMDGVPLSLAANQYSAVKLNLKPTFNPTMGYVEYVVPAVFVLILQQTLI
MAAGLMVGTQKHGHGYWTSQPRWKLLAVRTLVLVCVYYLLSAYYFGASFT
MHQVNTLGHATQLLTLLLPFLIASCLAGYWLGELLPRRELVTLVVLISSM
PLIFLAGFIWPVEMIPTPLLWLAQLSPSTNAIKGFLALNQMGASWQQIAN
YWSTLWLVAAFWLVLCLFQTVQQRRAAKRLA
>gid:515141  VV1600  ABC-type multidrug transport system, permease component
MKPQLSQLHVLRHDKWLLSCLTWIPILLALLIWGVFSAGIARDLPIGVVD
NAHSTLSRKLTHMLDASSTMSVDYQFSDVLQAKNAMIEGKVYAYVIIPDH
FDRDIYLQRAPQVSVFYNSQYILIGRLINSAVVQAQGFFNAGLETMKSLS
HGNSTVQGALGNAVTISTQISPLFNQNTNYAQFLVSAVVPAIWQIMIVVC
SILILAANLRVYARKPEHLDRWLGTQPFRVISKTLAAYLPIFLLHGFAFL
FWFYFMLDWPFQGHLLPIMIAQLATTIACMIMGAFFFFMTLDAARAMSFA
GAFTAPSFAFMGITFPVSDMGSLAQFWRSLLPISHYIEVQVAQASYGTSA
LTSLTHLLPMVGYVLPAFLAVALAKRHLKKTEATNVPV
>gid:515185  VV1644  ABC-type multidrug transport system, ATPase and permease component
MLSTSDTISRSWLLTQAKKHKSKLVFANLIAIVATLVSVPIPLLMPLMVD
EVLLDQPGKGLAAMNTLLPQAWQTPTGYIFLTLLLVILMRITSQALNILQ
SRQFTLVSKTITYQMRAKMIDKLGRISIRQYETRGSGGINAHLITDIETI
DQFIGSTLAKFVISLLTVVGTAGVLLWLEWRLGLFILLVNPIVIYFSRKL
GSKVKHLKKRENQAFEQFQNRLVETLDGIYQLRAANKEREFLSELKQQAD
QVRLNADKYAWQSEAAGRVSFLLFLLGFELFRAVAMLMVLFSDLTIGQIF
AVFGYLWFMLTPVQELLGIQFSWYSAKAALTRINALLELEEEYRPESKVN
PFTDGKEIDVSVENVSFSYNSETTVLNQLNLRIPAGKKVALVGASGGGKS
TLIQLLIGVYRQDSGVIRYNNESSDDIGFELIREKIAVVLQQPILFNDSL
RHNLTLGGDYDESALWQALEVAQLQDVISQLTAGLDTQVGRNGIRLSGGQ
RQRLAIARMVLSDPQFVILDEATSALDTATEAALHRALNEYLKGKTTLIV
AHRLSAVKQADLIYVLEDGQVTQSGTHTELVEQDGLYQTLYGSVQSHAS
>gid:515271  VV1730  Na+-driven multidrug efflux pump
MAFADRKHPNVPRTLSIFIFFLNNGVNVHRYKKEASSLIKLATPVLIASV
AQTGMGFVDTVMAGGVSATDMAAVSVAASIWLPSILFGIGLLMALVPVVA
QLNGAGKREQVPFEIQQGAVMALLISIPIIGVLFQTQWILGYMNVDAVMA
TKTIGYIHAVMFAVPAFLLFQTLRSLTDGLSLTKPAMVIGFIGLLLNIPL
NWMFVYGKLGAPALGGVGCGVATAIVYWIMFLLLLLYVTTSQRLRQVQLF
TTFHPPQLNAQVKLFKLGFPVAAALFFEVTLFAVVALLVAPLGSTVVAAH
QVAINFSSLVFMLPMSIGAATSIRVGHMLGEKSTEGARIASHVGILVGLS
TAVFTALLTVILREQIALLYTDNRVVITLAMQLLIFAAIYQCTDAIQVIA
AGALRGYKDMRAIFNRTFIAYWLLGLPTGYVLGLTDWIVEPMGAQGFWIG
FIVGLSSAAAMLGVRLHWLHRQNDEIQLNYEAR
>gid:515346  VV1772  probable transmembrane protein
MLILNQSNQDSMARKNDGLLWHLMDAPWWVSVLFAAIAYIGLSFVLPMLA
MSSENFIFNSVAPNLPILAPYVAFTLLIPAPVALFKQLSRQRQYSTTTNE
IASQGTTAALNNLSWLEFESYIGEFFKQQGYDVKQAFSQKPDGGVDIWMR
KDGQLTLVQCKHWKARKVGIQILREMYAVMIEHNASKMIIVTSGDFTSEA
IKYALDKRLWLINGGELVHMIEQVRNRPTEQAVEVTPPKSATPLCPSCHA
PLVMRTAKRGQNKGNQFYGCSSYPRCRYTKDISAA
>gid:515777  VV2045  ABC-type multidrug transport system, ATPase and permease component
MKIFWNLRWFFKLRWKHYCGSILLFMLISAMQLVTPKAVGHIVDGIVANT
MSATEMLQWFAGLTLIMFAIYGCRVLWRVWLFGASIELGSILRNRLYQHL
SKQPPRFFERYKTGDLMARGTNDVKNVVVTAGEGVLTAADSLITGIAVLI
IMVTQISWKLTVMALLPMPFLAITIFYIVRILHQRFRIAQEAFSELSDLT
QESLNGVRMLRAFGLEEQEQARFEKMVDETGDKNIAVARVDARFDPAIQL
SIGLSFFLSISVGAYLVHQKAITLGDLTAFTMYLGLMIWPMLAFAFLFNI
LERGSAAWNRLEEIFQQEPEIKSGDLPLTQSAQPLAIEIDHYHWNADLPA
ALSQCHITLQPGAMLGIAGPVGSGKSTLIALLLRQQELKQGDIRYGDISL
KQANLEQWREKFAVVSQTPFLFSCSIYDNIALGKPDASQQEVYQAAKLAC
IHDDILKFPDGYDTEVGEKGITLSGGQKQRIAIARAMLLNAEILILDDAL
SAVDGRTEHEILRNLEQFYRHQSLIVIAHRLTALEQANEIVVFNHGHVAE
RGNHASLIGAQGWYAEMYQYQQLEQAMEEAN
>gid:515778  VV2046  ABC-type multidrug transport system, ATPase and permease component
MKKTTLKRLFAYPLAQPKPMMTGLVFLLIAAVSNAGGPWLIQHFIDEHIT
KDDYTQQTLILLASGYIGLLLCSALFQYLQGLQFNIVATGIIKTIRKQAF
NHVIKQPLSAFDYTPTGKLVSRLTNDTESLQQFYELLIASVVKNLVMILV
MLGVMLILSWQLTLVVLVLLPVVVGFMVLFQKLSTHAYRVMRDLLTDING
NMSESIQGMSVIQLMRQEKRFNLQFNQLTEQHFNAGRKVIKLNGILLRPL
MDLLAGIALLTLVAIFGFSGTELIGVGVLYAFISYLGRITEPLIEMTQQL
ALLQQALVASERIFEMMDAPEQSYGHDQQPLKSGSIAIEQLSFSYDGKQQ
VLKQIDIDVEHQQFVALVGHTGSGKSTLASLLMGFYPVSQGKLKLDGRPI
ASLAKSVLRKDVAMVQQDPHILPTSVRENIALGREVSDDIIWQSLEQVGL
AEQIKRYPQLLDTQLGQGETNLSAGQKQLLAMARVLIAKPKILILDEATA
NIDSGTEALIQRSLNALRHDMTLVVIAHRLSTIMEADKIVVLHHGDLVEM
GSHKQLLAQQGRYAQMYQLQQAGQHIKEIEQQEEQELEQAS
>gid:515934  VV2202  type I restriction-modification system methyltransferase subunit
MNNKLMNIIELIRKDTGINNAIDAVEQLALLLLVRYTHEVASNEISKENH
IDSFKNLFFDLNDFSKDGLVIDFYTLRDKLNHIVVNCRFSENELSHSVFS
RNNWEKIENILDQIPFRIRSTKILDLVIHRLEELDLSEGIEIDFDHLLLN
MVKDSGSSGAYYSPRPLIKAMVRVLNPKPLATVYDPAMGTGGVFVEAKKH
AKGKSCFNGLSFIGNDLSPFAHLIGALNLLLNDIDISGVSISDSLLDRDC
QQYDFVISGVPFGKVNELTKYEYYYHGYSGSLEAMFLKHTMDKLAKGGRA
AIVIPDGILFGNASHLDELKRQLLTQFNLHAVLSLPKGTLAPYSGVKVSV
LFFDNTVSEKDIWFYELRTNKPLSKVNSITDSDFEDFTSLYERREVSENS
CLISKESLLQDKTLNLSFSLPKTEAGLKFDKQEMIASLKSEQLSLVTSIE
NHFDYMSLNLECKYIHQVKLKDICKLRSGDKLNKSEVMDSGEFPVYGGNG
VIGFNVEPNRHGDSIVIGKVGAHCGNIHFSTQPYWLTSNAMSLELLDTTK
VYLPYLAHVLKSLELNNLATGTAQKFISINKLYEVEVSLPSLEKQREMSE
WFTSIEESKSKIQSLLADFSRNLGTISTESITEKALKG
>gid:515936  VV2204  putative type I site-specific restriction-modification system, R (restriction) subunit
MFNEQTVTENGIIDRLKGLSGLKWNYCHGESLPKQTHDIFVDTWLKDALC
SLNPAIGNYPDYADEVIYKLRGLMLEAKHTGLVKANENFHEWLMAEKSLP
FGENGDHITIKLIDFDTPENNHFVVSQQVHFIAATEVFFDIVLYVNGIPL
VVGEVKSATRPSVTWQDGAADFIGGQKHYWKNVEPFFVPNLMCFASEGRT
FAYGAINARVKDWGPWHKTDQRDEIPASLATVLDSCEGLLNPETLLQMLE
SFALFSTVKTGKDTPPKRIKILPRYPQFEAAKQIVERVKKGYPKKGLIWH
FQGSGKSLLMLYAARMLRADNKLKNPTVLIVVDRRDLDSQINETFCGADV
KNLIKVQSCRKLGEHIEQDSRGILITTVFKFKDVEIDESNENGLNSRDNI
IVLVDEAHRTQEGSLGDKMRWALPHAHFYGLTGTPISGIDRNTFKLFGAE
EDEGRYMNRYSYKQSIRDKATNAVKFEPRLAELRVDRAAIDEAFEQMVKD
NDLDDDEKMALSKRAGRLAIMLKAPKRMAAVSEDIANHFVSHVKPKQMKG
MVVVYDRDACVQMYYLLGKKLGFDAVEVVMNVDQAPIKDEDASKKGKVNK
DWRKWKQDLELPILESDFERWQEIDGNDQKQKSLIEDYKDPKQPLQLLIV
TAKLLTGFDAPICYCMYLDKPLRDHTLLQAMCRTNRLYETDNVSKQMGLI
IDYLGVFENLRTALAYDPEEIDGVVEGIEAFKELLPAQLDKCLSFFPNVD
RTIDGFEGIMAAQACLPTNEKRDEFAASFGVLAKLWSAINPDAFLTPYRA
DYKWLVQIYESVRPVGQTGSLVWAALGPETIKMIHEHTDINRIRDDIDEL
VMDEHAIFTLTEKEQEKRASQLEIDLMGRLRGSGNPKFIALGERLEKLRQ
DYEAGVIKAIDWLKGLLDTAKDTVQAERETGDSPVTQEDNKQALTKLFLE
TRPESTPKLIGDVVEQIDKIVKAKRFKGWQSSNSGPREIQKALLLTLAQF
GLGKDKELFAKAYGYIEEHY
>gid:515937  VV2205  type I restriction-modification system, endonuclease S subunit
MTMKQLPEGWQMVKFGDIAKHISKRVEPSETELEVYVGLEHLDPDSLKIK
RHGVPSDVAGQKLLVKKGQIIFGKRRAYQRKVAVADWDCICSAHAMVLEA
NPKTVLPEFLPVFMQSGYFMERAIAISEGSLSPTIKWKVLEQQKFSLPPL
ELQSKLIARLSKIENTYDLSCQVENAARSLYKALLFATFEKSSETKKLKS
YIRNISSGKSISAASIPADVNEFGVLKVSAVNNGSFNPGENKLVKGDKIS
LLKNHVMANDLLMSRANTAELVGDVCIVDKTSTKLFLPDKLWKIEPINEH
YKLWLFHLLRFLKLNGTLASLSSGTSGSMKNISQKKLLEIDVGDSEKAQE
IGEVLQSAFLCVESSSMRVKAILELYKEVLQKSFANVGE
>gid:515938  VV2206  type I restriction-modification system methyltransferase subunit
MVRWLGVLGVSILMNKNKLEDLLWGAAEFLRGQIDASDYKQYVFPLLFFK
RLSDVYLEEYNEALELHEGDAEYAAMSMYHRFDIPEEASWEKVRNTSKDI
GEAIQNALRLIEAKNERLHGVFGDAQWTNKERLPDHLLSDLIQHFSKIPL
GIKSVAQDDLGEAYEYLIKKFADDSGHTAAEFYTNRTVVHLMTRIMKLKP
GESAYDPTCGTGGMLLNAVMDLRSQGEEWRGVHLYGQEVNLLTSAIARMN
MFLHDIEEFDVMRGDTLGDPKFIENDQLKQFDVIFANPPYSIKKWNREKF
AADPYGRNMYGVPPQGCADYGFYTHIIKSLKPDTGRAAMLWPHGVLFRDS
EQAIRKQVIESDIIEAVIGLGPNLFYNSPMESCVVVLNCNKPFERKNKIL
FINGVEHVTRERAHSRLSDDDLDVLCEAYFKPDSHGDIAALVDLDDIREN
QHNLSIPLYVQAQTDTEVHDIEHAIEEWKVSRVQLKKQTNKLFQSLAELG
YTAESKVEQ
>gid:515940  VV2208  type I restriction-modification system methyltransferase subunit
MTLINLKDLEAHLWHAAHIITGPIDASDYKTYIFPILFFKRICDVYDEEF
EDAMEQVGDEELAKGDMFHRIQIPANCHWKDVFAETKDIGQALKDSFRGI
ELENPQLHGIFGDASWTNKERLSDELLSTLLNHFNKVNLGVSSVRNDDMG
RAYEYLIKRFADKANKKAGEFYTPRTIVRLMVNILDPQANESVYDPACGT
GGMLLETIHHVKENGGDPRLLKIKGQEKNLTTEAIARMNLFLHGQEDFEI
VRGDTLRDPKFLKNDQLENFDCVIANPPFSLKEWGYDYWTSDPYGRASFG
LAPKTNGDFAWVQHMFASLNDEGRMAVVLPHGVLFRGGAEGKIRTKLLKE
NRIVAVIGVASNLFYGTGIPACILVLRKVRPEEHKDHVLIVNAEEIFTKG
RAQNTLSEPQADEIYGIYQKMRTKGPKVDDIEGVARWVPHSEIEENDFNL
NIARYVQKPLEEETISVEEALKDFQKKLSALEQAEQELEALLIKEGFEL
>gid:516091  VV2357  transport ATP-binding protein MsbA
MKKKNHSFMSINTDESTWRTFKRLWTFIRLYKSGLAVAVVALIINAVSDT
YMVSLLKPLLDEGFGSAESDFLRTLPLLVFGLMFIRGISSFVSTYCLSWV
SGNVVMQVRRMVFNHYMQMPVSYFDKEKSGSLLSRITYDSEQVSAATSQA
LVSIVREGTSIIGLLVLMFYNSWQLSLVLILVAPVVAWAIGFVSKRFRKI
SKNMQTTMGIVTSSAEQMLKGHKVVLSYGGQEVEKSRFDVVSNQMRQQSM
KLITAQAAANPIIQMIASIAIVVVLYLASVDTIKDQLTPGTFTVVFSAMF
GLMRPLKALTNVTSQFQRGMAAAQTLFALVDLEPEKNTGTYSVERAKGEV
NVKDISFTYEGAEKPALSHVSFDIPRGKTVALVGRSGSGKSTIANLFTRF
YDVDSGEIQLDGVDVRDYELKNLRTQFALVSQNVHLFNDTIANNIAYAAG
DKYSREDIERAAELAHAMEFISKMENGLDTVVGENGASLSGGQRQRVAIA
RALLRDAPVLILDEATSALDTESERAIQSALDELQKNKTVLVIAHRLSTI
EKADQILVIDDGAVVERGSHSELIEKDGAYAQLHRIQFGEG
>gid:516097  VV2362  ABC-type antimicrobial peptide transport system, ATPase component
MHLLLNLLRPSDMNKLLQCHQVSKIYREGEFETEVLKGVDFELEQGELVA
IVGTSGSGKSTLLHILGALDDATHGEVAFLDYQLSALSGNKQAQVRNQHL
GFIYQFHHLLADFTAVENVAMPLLIGGKSPKQAKLAAEALLEKVGLQHRM
HHRPSELSGGERQRVAIARALVNKPALVLADEPTGNLDHKTALQIYDLMR
ELNRESGTAFLVVTHDNELAAKMDRILYMQDGVLASDNR
>gid:516432  VV2693  Na+-driven multidrug efflux pump
MMNTSIYRQFWRYTIPTIAAMLVNGLYQVVDGIFIGHYVGAAGLAGINVA
WPLIGSILGIGLMVGVGTGALASIRLGEKQPQKAQAVLSTGLVLLLLMSP
VVSILLWCFADDFLRLQGAQGEVFQLGLQYLDVLVFSCLFTLGSIAMPIL
LRNDGSPNLATMLMVLGAITNIVLDYLFIGLLQWQLTGAAIATALAQMVV
LLVGLSYFFSRKAKLRLSKHNFSFQWRLLPQIFAIGTSSFFMYAYGSMMV
ALHNSLLLSYGSPVLVGAYAILGYIIVVYYLIAEGIANGMQPLASFYHGA
GHSDNIKKLLKIAMSSAVLTGMVFIGLLNIFPEQVVAVFNANDAELTQHT
ITGIRLHMFAMFLDGFLVVTAAYYQSVNRGGKALFVSIGNMMVQLPFLFI
MPKLLGITGVWLAFPLSNIALTLVVAIMLWRDIKRMPKNQWVEA
>gid:516466  VV2725  putative multidrug resistance protein
MLSVIDAVLSRSRTMMTLLVMILLAGIGTYMTIPKESSPDITIPIIYVSV
GHQGISPTDAERLLVRPIEQELRSIEGVKEMTSTASEGHASVMLEFTVGV
DLAKAMADVRDAVDLAKPKLPADSDEPTVNEVTLASEEPVLSVVLYGTLP
ERTIVQVARQLRDKLESYRQVLEVDIAGDREDIVEIIVDPLLMESYGLDQ
GDIYNLIALNNRVVAAGFVDTGYGRFSVKVPSVFDSLKDVLELPIKVDGK
QVITFADVATVRRAFRDPESFARLDGKPAVVLDVKKRAGENIIETVELVK
RVIEEGQKRADWPDNLLVKYTWDQSEDVELMLNDLQNNILSAIILVVIVI
IAILGVRTALLVGISIPGSFLTGLLVLAVFGLTVNIVVLFSLIMAVGMLV
DGAIVVTEFADRRMQEGVERKQAYRDAAKRMAWPITASTATTLAAFAPLL
FWPDITGEFMKYLPLTLIATLAASLIMALLFVPVLGGLIGKPQNVSSENQ
RRMVALHNGEFDKATGITKLYYHTLAIAVRHPLKILLSAILMAGGVGFAY
NKAGLGAEFFPEVDPPFFTVKVRSYGDLSIFEKDVVMRNIEQVMLGHDEF
ESVYTRTGGDDEIGQIQITPVDWQYRRKVKEIIDELKQTTSTFSGVEIEY
KFPDAGPPVEHDLVIEMSSRIPEHLDDAAKVVRHWADNNPALTNLSDTSS
KEGIDWQIDIRRDDASRFAADATLVGNTVQFVTNGLKIGDYLPDDANEEV
DILVRYPEEKRDIGRFDQLRVKTPAGLVPITNFAQIKPEPKQDTIKRIDG
QRVINVMADMVEGYNLALELPKIEQALSELGLPEGVEFRIRGQNEEQEHS
SAFLQNAFMIALAVMALILITQFNSFYQAFLILSAVLFSTVGVFAGLLIF
QKPFGVIMSGIGVIALAGIVVNNNIVLIDTYNQLRQRGLDKEEAILRTGV
QRLRPVMLTTVTTILGLLPMVLEMNIDLINQKIEFGAPSTQWWSQLATAV
AGGLAFATVLTLVLTPCLLMLGREHRSVKEDDDVEEDLIDDVHTDIPPAA
SSESGKVVGL
>gid:516506  VV2765  ABC-type multidrug transport system, permease component
MNRRRRSNMYRLYWTAFCSLLTKEINRFTRIWVQTLVPPAITMTLYFIIF
GSLIGSRIGEMNGFSYMEYIVPGLIMMSVITNSYSNVASSFFSAKFQRNI
EELLVAPVPNYVIIFGFVMGGVARGLLVGAMVTMVSLLFVDLQVEHWGII
IATVFLTSVVFSLGGLINAVFARTFDDISIIPTFVLTPLTYLGGVFYSIQ
LLPEFWQGVSQINPIVYMVNAFRYGFLGVSDVGIATSFTVLSAFVVLLYG
VAHYLVTRGIGLRS
>gid:516507  VV2766  ABC-type multidrug transport system, ATPase component
MYALQIEQLRKTYAGGFEALKGISLGVQEGDFYALLGPNGAGKSTTIGVI
SSLVNKTSGNVKVFGYDIDRDLELAKQHLGLVPQEFNFNQFETVEQIVLQ
QAGYYGVPRELAKQRAEKYLTKLDLWEKRKERARNLSGGMKRRLMIARAL
MHEPKLLILDEPTAGVDIELRRSMWEFLKEINQKQGITIILTTHYLEEAE
MLCRNIGIINRGELIENTTMKSLLAKLDVETFILDLAPNSPMPCLEGVVS
SRVENDSLEIEVEKTQPLNHVFSQLSEQGVMVMSMRNKANRLEELFVNIV
REQAKEK
>gid:516517  VV2776  AmpD protein
MQAVITQGWLEGVKRVSSPFFDARPQGEPISLLVVHNISLPPGQFGGHYI
EDFFQGQLDPSEHPFFQVIHQMRVSAHCLIKRDGEVVQFVSFDDRAWHAG
ASSFAGVERCNDYSIGIELEGSDFVAYTEAQYQALSELSKTLMRQYPHIT
LPRITGHQYIAPLRKTDPGLSFDWRYYRTLLSQNGAVAKM
>gid:516906  VV3108  Na+-driven multidrug efflux pump
MLDKHGLLSAPIAETLRKMTVPMIFGMVAILMFNLVDTFFISLLGTEALA
AISYTFPVTFAVNCITMGIGVGLSTSIGRLLGQGEAHQAARFTTHGLLLA
VVLVALASTLGFFTVTPLFTLLGAKEALIPLIGQYMHVWYLTIPLLVIPM
AGNSAIRATGDTKTPAKIMMLAGLINGVLDPLLIFGIGPFPELGIQGAAI
ASALSWLGALIGSFYVLIQRERLLGLPQWQRLKEDWQQILKVGTPAALSN
AMNPLSGAILMMMLSSHGTAAVAAYGAAQRIESILILVLMALTSALTPFM
AQNFGAKNPQRAFQGLFVSMRFSVLFQGLVFLMMVPLSIPLAALFSQEQA
VRDLLWHYLLVVPISYGFLGIVMMLVSGLNAMHQPLNAFRWSVIRLFVFT
LPAAYLGSWLYDIEGLFIGIAVGNILVGLCSYLYALKQRKQQLATLVP